04582nam 2200709 a 450 991097225320332120251017110121.0978661321335897803092250520309225051978128321335612832133549780309162982030916298X(CKB)2550000000043071(EBL)3378796(SSID)ssj0000539524(PQKBManifestationID)11324607(PQKBTitleCode)TC0000539524(PQKBWorkID)10570807(PQKB)11319470(MiAaPQ)EBC3378796(Au-PeEL)EBL3378796(CaPaEBR)ebr10488616(CaONFJC)MIL321335(OCoLC)923283602(Perlego)4739880(DNLM)1568300(EXLCZ)99255000000004307120110827d2011 uy 0engurcn|||||||||txtccrThe new profile of drug-resistant tuberculosis in Russia a global and local perspective : summary of a joing workshop by the Institute of Medicine and the Russian Academy of Medical Science /Institute of Medicine of the National Academies and Russian Academy of Medical Sciences1st ed.Washington, D.C. National Academies Press20111 online resource (150 p.)"Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy.9780309162975 0309162971 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 A Global Perspective on Drug-Resistant Tuberculosis""; ""3 Drug-Resistant Tuberculosis in the Russian Federation""; ""4 Transmission and Infection Control of Drug-Resistant TB""; ""5 Diagnosis of Drug-Resistant TB""; ""6 Treatment of Drug-Resistant TB""; ""7 TB and Drug-Resistant TB in Vulnerable Populations""; ""8 The Second-Line Drug Supply Chain""; ""9 The Development of New TB Diagnostics and Drugs""; ""10 Convergence of Science and Policy to Create a Call for Action""""References""""Appendix A: Agenda""; ""Appendix B: Summary of a Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Held May 24-25, 2010, Moscow, Russian Federation""; ""Appendix C: Participant Biographies""An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.TuberculosisRussiaTuberculosis614.409542Olsen Steve1807544English Rebecca1807545Claiborne Anne1807546Institute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.Institute of Medicine (U.S.).Board on Health Sciences Policy.Rossiiskaia akademiia meditsinskikh nauk.MiAaPQMiAaPQMiAaPQBOOK9910972253203321The new profile of drug-resistant tuberculosis in Russia4357330UNINA